Synthesis of potent and selective inhibitors of human plasma kallikrein (original) (raw)
Bicyclic Peptides with Optimized Ring Size Inhibit Human Plasma Kallikrein and its Orthologues While Sparing Paralogous Proteases
John Tite
ChemMedChem, 2012
View PDFchevron_right
Biochemical characterization of a novel high-affinity and specific plasma kallikrein inhibitor
Parth Akbari
British Journal of Pharmacology, 2011
View PDFchevron_right
Discovery of a new isomannide-based peptidomimetic synthetized by Ugi multicomponent reaction as human tissue kallikrein 1 inhibitor
Ana Carolina Rennó Sodero
Bioorganic & Medicinal Chemistry Letters, 2017
View PDFchevron_right
Design of kallidin-releasing tissue kallikrein inhibitors based on the specificities of the enzyme's binding subsites
Luiz Juliano, Maria Helena Sedenho Cezari
1997
View PDFchevron_right
Specificity of S′1 and S′2 subsites of human tissue kallikrein using the reactive-centre loop of kallistatin: the importance of P′1 and P′2 positions in design of inhibitors
Daniel C Pimenta
Biochemical Journal, 2003
View PDFchevron_right
Mapping of Human Plasma Kallikrein Active Site by Design of Peptides Based on Modifications of a Kazal-Type Inhibitor Reactive Site
Misako Sampaio
Journal of Protein Chemistry, 2000
View PDFchevron_right
Natural and engineered kallikrein inhibitors: an emerging pharmacopoeia
Joakim Swedberg
Biological Chemistry, 2000
View PDFchevron_right
The natural flavone fukugetin as a mixed-type inhibitor for human tissue kallikreins
Teodorico C. Ramalho
Bioorganic & Medicinal Chemistry Letters, 2016
View PDFchevron_right
Isomannide-Based Peptidomimetics as Inhibitors for Human Tissue Kallikreins 5 and 7
Thalita Barros
ACS Medicinal Chemistry Letters, 2014
View PDFchevron_right
Natural and synthetic inhibitors of kallikrein-related peptidases (KLKs)
Peter Goettig, Viktor Magdolen
Biochimie, 2010
View PDFchevron_right
Identification by in silico and in vitro screenings of small organic molecules acting as reversible inhibitors of kallikreins
Chahrazade Amri
European Journal of Medicinal Chemistry, 2013
View PDFchevron_right
Substrate-Guided Design of a Potent and Selective Kallikrein-Related Peptidase Inhibitor for Kallikrein 4
laura NIGON
Chemistry & Biology, 2009
View PDFchevron_right
Pyrido-imidazodiazepinones as a new class of reversible inhibitors of human kallikrein 7
Feryel Soualmia
European Journal of Medicinal Chemistry, 2015
View PDFchevron_right
Obtaining a family of high-affinity, high-specificity protein inhibitors of plasmin and plasma kallikrein
Arthur Ley
Molecular Diversity, 1996
View PDFchevron_right
Novel peptide inhibitors of human kallikrein 2
Can Hekim
Journal of Biological …, 2006
View PDFchevron_right
Isomannide derivatives as new class of inhibitors for human kallikrein 7
Luiz Juliano
Bioorganic & Medicinal Chemistry Letters, 2012
View PDFchevron_right
Activity assay based on the immobilized enzyme kallikrein and mass spectrometry
Carmen Lúcia Cardoso
Frontiers in Analytical Science
View PDFchevron_right
Synthesis and Structure–Activity Relationships of N-(4-Benzamidino)-Oxazolidinones–Potent and Selective Inhibitors of Kallikrein-Related Peptidase 6
Natalia Ignatenko
View PDFchevron_right
Human plasma kallikrein processing: proteolysis as an alternative control
Guacyara Motta
Agents and actions. Supplements, 1992
View PDFchevron_right
Inhibitors of kallikrein‐related peptidases: An overview
Dominique Arama
Medicinal Research Reviews, 2017
View PDFchevron_right
Differences in substrate and inhibitor sequence specificity of human, mouse and rat tissue kallikreins
Daniel C Pimenta
Biochemical Journal, 2004
View PDFchevron_right
Toward the First Class of Suicide Inhibitors of Kallikreins Involved in Skin Diseases
Xiao Tan, Feryel Soualmia
Journal of Medicinal Chemistry, 2015
View PDFchevron_right
Specificity of human tissue kallikrein towards substrates containing Phe‒Phe pair of amino acids
Lee Chao, Daniel C Pimenta
Biochemical Journal, 1999
View PDFchevron_right
Novel Inhibitory Activity for Serine Protease Inhibitor Kazal Type-3 (Spink3) on Human Recombinant Kallikreins
Diego Assis
Protein & Peptide Letters, 2013
View PDFchevron_right